Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Colorcon
Baxter
Boehringer Ingelheim
Johnson and Johnson

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR ANDROID-F


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Android-f

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02107014 ↗ Low Dose Naltrexone (LDN) Immune Monitoring Completed Stanford University N/A 2014-03-01 We have found that low dose naltrexone (LDN) can substantially reduce pain associated with fibromyalgia syndrome. We believe LDN may work via novel anti-inflammatory channels. The purpose of this study is to determine if LDN lowers inflammatory markers in individuals with fibromyalgia.
NCT02107014 ↗ Low Dose Naltrexone (LDN) Immune Monitoring Completed University of Alabama at Birmingham N/A 2014-03-01 We have found that low dose naltrexone (LDN) can substantially reduce pain associated with fibromyalgia syndrome. We believe LDN may work via novel anti-inflammatory channels. The purpose of this study is to determine if LDN lowers inflammatory markers in individuals with fibromyalgia.
NCT02897934 ↗ CWI and Discharge After Breast Cancer Surgery Completed University College Cork 2016-08-01 The objectives of this work are threefold: 1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery 2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care 3. To evaluate patient satisfaction with their care pathway
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Android-f

Condition Name

Condition Name for Android-f
Intervention Trials
Breast Cancer 2
Pain, Postoperative 1
Diabetes Mellitus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Android-f
Intervention Trials
Diabetes Mellitus 3
Diabetes Mellitus, Type 1 1
Postoperative Nausea and Vomiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Android-f

Trials by Country

Trials by Country for Android-f
Location Trials
Canada 4
United States 3
Switzerland 2
Ireland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Android-f
Location Trials
Vermont 1
Pennsylvania 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Android-f

Clinical Trial Phase

Clinical Trial Phase for Android-f
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Android-f
Clinical Trial Phase Trials
Recruiting 3
Completed 3
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Android-f

Sponsor Name

Sponsor Name for Android-f
Sponsor Trials
Stanford University 2
Penn State University 1
McGill University Health Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Android-f
Sponsor Trials
Other 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Colorcon
McKinsey
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.